Experiment 635032

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismGinkgo biloba (GINKGOACEAE)
CitationSTOPPE,G: SANDHOLZER,H: STAEDT,J: WINTER,S: KIEFER,J: RUTHER,E:. (1996). PRESCRIBING PRACTICE WITH COGNITION ENHANCERS IN OUTPATIENTS CARE: ARE THERE DIFFERENCES REGARDING TYPE OF DEMENTIA?- RESULTS OF A REPRESENTATIVE SURVEY IN LOWER SAXONY, GERMANY.. 29(4)
Amount utilized
Compound isolated
DiseaseA SURVEY USING EXEMPLARY CASE HISTORICES WERE PERFORMED. THE PRIMARY CARE PHYSICANS TREAT THE MAJORITY OF ELDERLY AND DEMENTED PATIENTS, THIS SURVEY EXAMINED THE DIFFERENCE IN TREATMENT OF SENILE DEMENTIA OF ALZHEIMERIS TYPE (SDAT) AND INVASCULAR DEMENTIA(VD). PIRACETAM (A/B: 25.6%-/30.9%). GINKGO BILOBA (24.41./28.4%) AND NIMODIPINE (14.1%/25.9%). WERE CHOSEN MOST FREQUENTLY AS THE DRUGS OF CHOICE BY THE PATIENT ASSESSMENTS.
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
ExtractTYPE EXT NOT STATED
GenderGIVEN TO BOTH SEXES